Bladder tumor ILC1s undergo Th17-like differentiation in human bladder cancer.

Neelam MukherjeeNiannian JiXi TanChun-Lin LinEmily RiosChun-Liang ChenTim HuangRobert S Svatek

Published in: Cancer medicine (2021)

hILC1s are increased in higher stage tumors among patients with muscle-invasive bladder cancer. These intratumoral hILC1s exhibit an exhausted phenotype and Th17-like differentiation, identifying them as potential targets for immunotherapy.

Keyphrases

muscle invasive bladder cancer
endothelial cells
spinal cord injury
risk assessment
climate change